Navigation Links
Nature's Bioceuticals Finalizes Agreement for the Purchase of Proprietary Weight Loss Formula
Date:11/11/2011

on, this release contains forward-looking statements.  Mistral Ventures, Inc. and/or Nature's Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature's Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as "expects," "intends," "believes," "anticipates," "should," "likely," and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Mistral Ventures, Inc. nor Nature's Bioceuticals assume any obligation to update any forward-looking statement.  Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company's financial statements by the Company and its Audit Committee; modification of the Company's accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.

Media Contact: Financial Insights
Phone Number: 888 656 3509
E-mail: investors@naturesbioceuticals.com
www.naturesbioceuticals.com


'/>"/>
SOURCE Mistral Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
2. Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
3. Natures Bioceuticals Finalizes The Purchase of Cold and Flu Formula
4. Natures Bioceuticals Tears Into the Multi-Billion Dollar Chronic Kidney Disease Market
5. FDA Finalizes Regulation For Certain Software, Hardware Used With Medical Devices
6. Scott & White Finalizes College Station Land Deal
7. Zimmer Finalizes Acquisition of Chinese Orthopaedic Implant Leader Beijing Montagne Medical Device Co., Ltd.
8. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
9. Signum Biosciences, Inc. Announces Collaborative Agreement with GlaxoSmithKline
10. Childrens Hospital Boston and Pfizer Enter Into Novel Collaborative Research Agreement for Muscular Dystrophy Therapeutics
11. International Isotopes Inc. Announces the Completion of an Agreement in Principle With Idaho State University for the Production of Copper-67 for Experimental Use in Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... and HAMPTON, N.J. , March 5, ... MNK ), a leading global specialty biopharmaceutical company, ... today that they have entered into a definitive agreement ... Inc. from a Madison Dearborn -led investor group ... Subject to customary closing conditions, the parties ...
(Date:3/5/2015)... 05, 2015 Research and Markets ( ... "Global Rising Stars Outlook 2015" report to their ... are being sought after with fresh vigor as new ... which is poised to bring a paradigm change in ... is the Stem cell therapy/Regenerative Medicine space. ...
(Date:3/5/2015)... -- According to a new market research ... Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User ... - Analysis & Global Forecast to 2019" , the ... $1,107.4 Million by 2019 from $887.8 Million in 2014, ... 4.5% during the forecast period. Browse ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Global Pharma Rising Stars Outlook 2015 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... STEWARTVILLE, Minn., Oct. 25 Rochester Medical Corporation (Nasdaq: ... close on Thursday, November 4, 2010.  The Company will then ...  The call will begin at 3:30 p.m. central time (4:30 ... by Thomson/CCBN and can be accessed at Rochester Medical,s website ...
Cached Medicine Technology:Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 2Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 3Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 4Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 5Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 6Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 7Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 8Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 9Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 10Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 11Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010 2
(Date:3/5/2015)... 2015 Shania Twain will be touring ... decade. She has hinted that this will be her final ... perform one last time. She has had a residency in ... sweetheart has millions of loyal fans around the world. After ... Canada, and on June 30th she will be at Madison Square ...
(Date:3/5/2015)... York, New York (PRWEB) March 05, 2015 ... of men who allegedly suffered heart attacks, strokes and ... prescription low testosterone therapies continue to move forward in ... Court, Northern District of Illinois. According to a Case ... set forth procedures for the use of master pleadings ...
(Date:3/5/2015)... Los Angeles, CA (PRWEB) March 05, 2015 ... online article titled “Butt Augmentation, Labiaplasty on the Rise, ... surveys reported by the American Society for Aesthetic ... Plastic Surgeons . Both groups reported a year-over-year doubling ... one of the physicians quoted in the article, this ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... in healthcare communications and education, announced today its ... (AMP), the nation’s only medical conference designed for ... ischemia and lower limb amputation due to vascular ... family of innovative, evidence-based publications and CME activities ...
(Date:3/5/2015)... Venice, FL (PRWEB) March 05, 2015 ... their 15th annual listing of “Pros to Know” in ... announce that two members of MEBC’s leadership team were ... Rhodes were nominated and received this award due to ... use of innovative methods for meeting and resolving client ...
Breaking Medicine News(10 mins):Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2
... Glenn Hackbarth (MedPAC) and Bruce Bradley (General,Motors) - ... 1 The ABIM Foundation,will dedicate its efforts ... concepts,of medical professionalism and accountability in health care ... In addition, the Foundation announced that officers of ...
... Care Advantage, JACKSONVILLE, Fla., July 1 ... home,health care agency with 11 years experience in ... in revenue. Home Care Advantage is the largest ... the largest,rehabilitation provider in Jacksonville, with its 143-bed ...
... -- The first batch of imported food,( ... for the Olympic Games has arrived. The 24.269 ... in Shanghai on June 18. To ensure the,smooth ... Quarantine Bureau,took great care in their preparations prior ...
... 20% of persons aged over 55 use colonoscopies for ... insurance funds have covered the costs since 2002. This ... Database published in the current edition of Deutsches ... , http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=60551 , The authors evaluated ...
... What began as a college course project to design ... their kind, designed as therapy for children with cerebral ... affects the development of the brain and the motor ... occupational therapy have been shown to be effective treatments ...
... junk food had higher cholesterol, blood fats into adulthood, ... -- Eating an unhealthy diet during pregnancy may raise ... and blood sugar levels, British researchers report. , In ... one group of females a diet of processed junk ...
Cached Medicine News:Health News:ABIM Foundation Announces New Focus and Governance 2Health News:ABIM Foundation Announces New Focus and Governance 3Health News:Jacksonville's Largest Rehab Provider Acquires Largest Home Health Agency 2Health News:China Improves Safety Management on Imported Foods in Preparation for Olympic Games 2Health News:Toys and technology for rehabilitation in cerebral palsy patients 2Health News:Toys and technology for rehabilitation in cerebral palsy patients 3Health News:Mom's Unhealthy Diet May Have Long-Term Impact on Baby 2
... Cortisol Range Verifiers have been validated for ... Immunodiagnostic Products Cortisol Reagent Pack and Vitros,Immunodiagnostic ... low and,high cortisol concentrations, close to the ... be used,to verify measurement of cortisol at ...
Rapid assay, results in 1 hours,Range 20-800 ng/mL; sensitivity 2.5 ng/mL,Can be used for animal sera; requires extraction protocol and steroid free serum...
... 1000 assays are designed for ... IMMULITE 1000, continuous random access ... in both design and operation. ... in a wide variety of ...
... XCAT 100 X-Ray System from KUBTEC is a ... two and three dimensional representation of the specimen ... reconstruction of specimen X-ray images, the micro focus ... level of detail in standard 2D images. The ...
Medicine Products: